|
Join us in accelerating research and advancing treatment for the more than 1 billion people worldwide living with obesity. |
|
BREAKING NEWS: Endocrine Society releases Scientific Statement on obesity that identifies areas of needed research. COMING SOON: Clinical Practice Guideline (CPG) on Pharmacologic Management of Obesity (coming 2027) |
Obesity Fellows Program: A prestigious experience focused on the latest evidence-based approaches in obesity care. Fellows will hear from world renowned experts in obesity care, engage in small-group case discussions, and have direct access to leading experts in the field.
Obesity Playbook (Includes New Information on the Medicare Bridge Program): The Obesity Playbook is an educational resource guide for policymakers on obesity and health. The Playbook includes up-to-date facts and figures, state of the science, policy recommendations, and a list of Endocrine Society members who are experts in the field of obesity.
Read recent articles from the Society's suite of scientific journals that advance our understanding of obesity and the roles of diet and exercise in metabolic health. Articles in this collection were curated based on citations, downloads, and editorial recognition.
Talking Obesity with Daniel Drucker, MD: Story of A Pioneer in Obesity Care
Research and Publications
JES Call for Papers on Obesity: Article types welcomed include research articles, brief reports, mini-reviews, and technical resources. Deadline to submit: October 1.
The important role of comorbidities in the management of obesity | JES
Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity | Endocrinology
Epigenetics and childhood obesity: DNA methylation coordinates environment and gene regulation | Endocrine Reviews
Closing the Obesity Diagnosis Gap: A New EHR-Based Measure Could Improve Population Health Outcomes | Endocrine News
Advocacy & Community
Obesity Playbook (advocacy): Educational resources for Congressional staff on obesity and health. Playbook includes up-to-date facts and figures, state of the science, and policy recommendations.
Obesity Special Interest Group (SIG) (community): Group of members interested in obesity education, research, networking activities, and more.
2026 Obesity Fellows Program (education): Obesity Fellows program, September 18-19, 2026, is an exclusive, application-based, educational activity.
Strategies for Obesity and Weight Management at CEU 2026 (education): Clinical Endocrinology Update (CEU) 2026 sessions, online Oct. 22-24, addresses GLP-1-induced sarcopenia and preventing post-treatment weight regain.
Two Generations, One Challenge: Confronting Obesity in Pregnancy and Childhood's Metabolic Outcomes (education): Virtual of a live webinar.
Reprogrammed by Chemicals: The Epigenetic Link Between Environmental Exposure and Obesity (education): Member-only webinar sponsored by the Society’s Obesity and EDCs Special Interest Groups.
Defining Disease or Delaying Care? A Conceptual and Clinical Appraisal of the Lancet Obesity Framework (clinical practice guideline): Response to Lancet article that redefines obesity based not only on BMI but on whether excess body fat causes health problems.
Pharmacologic Management of Obesity (clinical practice guideline): Open comments for Pharmacologic Management of Obesity: An Endocrine Society Clinical Practice Guideline is in development.
Taste Changes with Semaglutide (podcast): Endocrine Feedback Loop podcast examining whether semaglutide alters taste recognition, tongue gene expression, and brain responses to food-related cues.
Step Counts Decline Among GLP-1 Users (video): People who lost weight with GLP-1 anti-obesity medications tended to log fewer daily steps.
Funding for the Center on Obesity was provided in part through support by Eli Lilly and Company.
We are at the forefront of research and clinical practice using new hormone-based therapies, including GLP-1 based medications, to treat obesity and related medical problems.
